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Purpose:
UnitedKingdomprostate cancernursing care is providedbyavariety
of urology and uro-oncology nurses. The experience of working in
multidisciplinary teams (MDT) was investigated in a national study.
Design:
The study consisted of a national survey with descriptive
statistics and thematic analysis.
Methods:
A secondary analysis of a data subset from a UK whole
population survey was undertaken (n = 285) of the specialist
nursing workforce and the services they provide. Data were
collected on the experience of working in the MDT.
Results:
Forty-five percent of the respondents felt that they worked in a
functional MDT, 12% felt that they worked in a dysfunctional
MDT, and 3.5% found the MDT meeting intimidating.
Furthermore, 34%of the nurses felt that they could constructively
challenge all members of the MDT in meetings. Themes
emerging from open-ended questions were lack of interest in
nonmedical concerns by other team members, ability to
constructively challenge decisions or views within the meeting,
and little opportunity for patients’ wishes to be expressed.
Conclusions:
Despite expertise and experience, nurses had a variable, often
negative, experience of the MDT. It is necessary to ensure that
all participants can contribute and are heard and valued. More
emphasis should be given to patients’ nonmedical needs.
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According toCancerResearchUK, for the last 40years,prostate cancer incidence rates in UK have morethan tripled. There were 47 300 new cases of pros-
tate cancer diagnosed in the United Kingdom in 2013. It is
the second most common cause of cancer in the United
Kingdom, and more than half the cases (54%) are in men
70 years and older causing around 11 300 deaths in the
United Kingdom in 2014. It has been estimated that, world-
wide, more than 1.11 million menwere given a diagnosis of
prostate cancer resulting inmore than 307 000deaths in 2012.1
The National Cancer Patient Experience Survey in
England has demonstrated that patients with cancer
Author Affiliations: Visiting Fellow (Mr Punshon), School of Health and
Social Care, London South Bank University; Professor in Clinical Nurs-
ing (Critical Care) (Prof Endacott), Plymouth University/Royal Devon and
Exeter Hospital Clinical School; Senior UrologyNurse Specialist and BAUN
President (MsAslett), Basingstoke andNorthHampshire FoundationTrust,
Hampshire; Urology & Continence Nurse Specialist (Ms Brocksom), St
James’s University Hospital, Leeds; Lead urology clinical nurse specialist/
prostate cancer advanced nurse practitioner (Ms Fleure), Guy’s and St
Thomas’NHSFoundation Trust;WorkforceAnalyst (MsHowdle),Mouchel
Management Consulting Limited and Centre for Workforce Intelligence;
Head of Outreach (Ms Masterton), Prostate Cancer UK; Research Assistant
(Ms O’Connor), Centre for Health and Social Care Innovation, Plymouth
University; Consultant (Mr Swift), Mouchel Management Consulting Lim-
ited and Centre for Workforce Intelligence; Lead, Cardiovascular, End
of Life Care (Mr Trevatt), London Region, NHS England; and Chair of
Healthcare & Workforce Modelling (Prof Leary), School of Health and
Social Care, London South Bank University, London, UK.
The authors report no conflicts of interest.
Correspondence: Geoffrey Punshon, BSc(Hons), London South Bank
University, FSHSC K2 Bldg, 103 Borough Rd, London SE1 0AA, UK
(punshongeoff@yahoo.co.uk).
This is an open-access article distributed under the terms of the Creative
Commons Attribution-Non Commercial-NoDerivatives License 4.0
(CCBYNC-ND), where it is permissible to download and share the work
provided it is properly cited. The work cannot be changed in any way or
used commercially without permission from the journal.
DOI: 10.1097/NUR.0000000000000308
210 www.cns-journal.com July/August 2017
Clinical Nurse SpecialistA Copyright B 2017 The Authors.
Published by Wolters Kluwer Health, Inc.
Feature Article
who have access to a clinical nurse specialist (CNS) gen-
erally report better experiences and understanding of the
disease.2Y5 Despite the known benefits of access to a
specialist nurse, the distribution of specialist nurses and
incidence-to-nurse ratios vary enormously indicating that
there is an inequity of access. Unlike other cancers, pros-
tate cancer nursing care in the United Kingdom is rarely
provided by a prostate CNS.6,7 This is corroborated by
the national cancer nursing census, which shows that only
2% of the specialist nursing workforce in England are pros-
tate specific, approximately the same number as a rare
cancer such as sarcoma.8
In the absence of a dedicated prostate cancer nursing
workforce, prostate cancer care in the United Kingdom is
provided by a variety of urology and uro-oncology nurses
alongside specialists from other fields including bladder,
kidney, testicular, and penile cancer, as well as benign dis-
ease. As a consequence, there are a variety of service
arrangements and intersections with a number of multi-
disciplinary teams (MDTs).6,7
Cancer care in the United Kingdom is delivered by
collaborative MDTs consisting of a core set of professionals,
which includes oncologists, surgeons, and CNSs.9 In the
United Kingdom, patients are not generally present at MDT
meetings. Because this study was carried out in the UKNHS,
all staff are salaried and do not receive a fee for service.
The national cancer peer review program, launched
in England in 2001, provided measurable standards to as-
sess teams’ adherence to the best practice guidance.9,10
These standards reflect best practice drawn from a com-
bination of research evidence, national consensus, and
expert opinion, and central to this approach was the
MDT. The MDT was promoted as the best practice in can-
cer care as a means of achieving more holistic cancer care
delivered in a timely way by a team of experts rather than
isolated individuals.11
The impact of working in MDT on team members is
not well understood,12 and the limited body of knowl-
edge seems to be contradictory. In a national survey of
team members carried out in the United Kingdom in 2014
(n = 2054), most respondents (90%) agreed that working in
MDTs was beneficial to the well-being of members, and
81% agreed that it improves job satisfaction.13 There is,
however, anecdotal evidence of autocratic practice and hi-
erarchical boundaries making teams dysfunctional and
participation stressful.14 Interviews with MDT members
in primary care (n = 121) identified sources of conflict and
barriers to conflict resolution, alongside team and individual
strategies to resolve conflict.15 However, an intervention
study conducted with teams in general internal medicine
did not achieve improvements in communication or collab-
oration because of lack of senior staff support or positive
role modeling,16 whereas an observational study revealed
hierarchical behaviors in interprofessional teams, despite
team leaders (physicians) espousing collaborative leader-
ship values.17Much of the research is focussed on theMDT
meeting and its function or validity. A study of 370 MDT
meetings,18 which looked at different long-term conditions
including cancer, found substantial diversity. This diversity
existed in the purpose, structure, processes, and content of
MDT meetings. Greater multidisciplinarity was not neces-
sarily associated with more effective decision making and
MDT decisions (asmeasured by decision implementation).
Decisionswere also less likely tobe implemented forpatients
living inmoredeprived areas.18 There is little presented in the
literature specifically about experiences of CNS in the MDT;
however, the work of Taylor and Ramirez13 for the National
Cancer Action Team provided very detailed responses from
cancer nurses as a subgroup. There seems to be no work on
the experiences of specialist nurses working in uro-oncology
who will also cover benign diseases.6
A detailed survey of the specialist uro-oncology nursing
workforce6 was undertaken in 2014 to look at many facets
of the role and gather demographic information about the
workforce providing care to men with prostate cancer in
the United Kingdom. Specific questions about the experi-
ence of working in the MDT were included in the survey,
and respondents were offered the opportunity to share
their experiences of MDTworking through a free text op-
tion where respondents could add detail and depth to
their responses. The original survey revealed a rich data
set of experiences of working within the MDT, and these
have been subjected to secondary analysis by the re-
search team.
METHODS
A cross-sectional survey was undertaken using a census
of the workforce similar to that used in the specialist can-
cer workforce.19,20 A secondary analysis of a subset of
the original data relating to experience of working in
an MDT was then carried out.
Sample
This is a whole population sample study. The available
population of specialist nurses working in uro-oncology
was determined by the British Association of Urological
Nurses membership and the previous national census8 to
be between 300 and 350 by headcount.
Data Collection Methods
A 24-item survey questionnaire, exploring demographic
data, caseload and workload, and experience of MDT
working, was developed for this population by consen-
sus using clinical, patient, and academic experts.7 The
questionnaire was designed to gather data on activity and
complexity of specialist nursing services provided includ-
ing work left undone and used a format similar to the
national optimum caseload modeling project.21 This was
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transferred to an online survey tool (administered using a
SurveyMonkey secure account). Ethical approvalwas sought
and granted by Plymouth University Ethics Committee. The
surveywas developed during April andMay 2014 and pilot
tested with a small sample from the study population. The
survey link was distributed through formal and informal
networks; mailing lists; the nursing press; targeted interest
groups such as the British Association of Urological Nurses,
NHS CHAIN (Contact, Help, Advice and Information Net-
work), and the UK Oncology Nursing Society; and social
media (Twitter) during June and July 2014. Participants
could only submit a single response from each computer.
Analysis of the survey took place in November 2014 to Jan-
uary 2015. The secondary analysis of the original data7 used
in this study took place in Autumn/Winter 2015.
The survey presented a number of consensus state-
ments. Of the 24 questions in the survey, three specifically
related to the experience of working in MDT. The first ques-
tion relating to the experience of working in MDT consisted
of 13 statements regarding MDT working, which respon-
dents could ‘‘agree’’ with or not (Table 1).
The other 2 questions relating specifically to the expe-
rience of working in MDT were open, free text questions,
which were included to allow participants to provide addi-
tional information or raise any other issues they felt relevant.
The responses were examined overall and, in addition,
by length of time in prostate cancer care and by pay band.
Data Analysis
Data were exported into Excel and modeled using de-
scriptive statistics, for example, demographics, pay band,
and length of service. Free text comments were analyzed
using thematic content analysis.22 Thematic content analy-
sis is the approach best suited to free text questions in an
otherwise quantitative questionnaire because it does not
rely on interpretation of data but instead reflects a ‘‘low
hovering over the data.’’22 Each comment was coded,
and themes emerged from the codes. Data excerpts are in-
cluded hereinafter alongside quantitative findings to
provide context. Excerpts are annotated according to job
title and pay band (eg, CNS/band 6). The secondary anal-
ysis presented here is confined to the subsection of the
survey, which examined the experience of working in
the MDT. To determine whether responses were equal
across different sectors of the workforce, responses were
broken down by pay band and by years of experience.
These are reported hereinafter.
RESULTS
There were 302 respondents in total. After cleaning, the
data from 285 respondents were used. Seventeen re-
cords were removed because they were incomplete
submissions or submissions from countries outside the
United Kingdom. Assuming the higher total of CNS
working in uro-oncology in the United Kingdom to be
350, this suggests a response rate of 81% after data
cleaning. The most common job title was CNS (n =
185). The responses were further broken down by the
‘‘Agenda for Change’’ pay band of their post. Agenda
for Change is the process in the NHS by which nursing
roles are allocated to 1 of 9 pay bands on the basis of the
knowledge, responsibility, skills, and effort required for
the post after a job evaluation. In general, the higher
banding requires greater knowledge, responsibility, and
skills.23 The most common band was Agenda for Change
band 7 (n = 174). However, in Scotland, 50% of the respon-
dents stated that they were paid on band 6. More than half
of the respondents (n = 158) hadworked in prostate cancer
care formore than 10 years. Few (n = 48) had come into spe-
cialist posts froma specific specialist nurse development role.
The results of the study are reported in full else-
where,6,7 and the results that specifically address working
in the MDT are reported here. The MDT is a key compo-
nent of cancer care delivery and is enshrined in English
cancer policy24; however, increasing workload and cultur-
al differences seem to present barriers for effective MDT
working. The breakdown of respondents by country is
shown in Table 2.
Overall Responses to the Survey
The overall response to the survey can be seen in the Figure.
Two themes emerged from the results: first, the functionality
Table 1. The Statements Presented as Options
in the Survey
& I work in a functional and efficient MDT.
& I work in a dysfunctional MDT where views are not respected.
& The MDT meeting pays attention only to medical issues.
& I am not always told of new patients by members of the MDT.
& Attending the MDT meeting is not applicable to my role.
& I do not attend the MDT meeting.
& I would constructively challenge all members of the MDT in
the meeting.
& I would constructively challenge some members of the MDT in
the meeting but not others.
& I would constructively challenge members of the MDTafter the
meeting/separately in private.
& I wait until after the meeting to challenge because there is not
enough time during the meeting.
& There are some members of the team I feel uncomfortable
challenging in or outside the meeting.
& I do not feel it"s my role to challenge other members of the MDT.
& I find the MDT meeting intimidating.
Abbreviation: MDT, multi-disciplinary team.
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and operation of the MDT, and, second, the confidence or
ability of the respondents to constructively challenge other
members of the MDT. Quantitative findings are presented
hereinafter in relation to these 2 themes; data excerpts
from the free text responses are provided alongside the
quantitative data.
Functionality and Operation of the MDT
Less than half of the respondents (n = 128, 45%) agreed
that they worked in a functional and efficient MDT. Re-
spondents agreed that they worked in a dysfunctional
MDT where views were not respected in 12% of re-
sponses (n =35), and 14% (n = 40) agreed that the MDT
meeting only paid attention to medical issues, whereas
27% (n = 76) agreed that they were not always told of
new patients by members of the MDT.
The free text comments (n = 42) were most extensive
in the questionnaire, with most comments expressing
concerns about conduct of the MDT meeting. Common
areas of concern relate to the lack of interest in nonmed-
ical concerns:
I don’t feel my views are valued at the MDT; they
certainly don’t ask for a nursing opinion. (CNS,
band 7)
The MDT is driven by medical diagnosis, due to the
number of patientswe have to discuss. (CNS, band 7)
The most common issue expressed by the respon-
dents is a lack of timeVlarge numbers of patients are
commonly discussed, and problems such as ‘‘the consul-
tant sometimes goes off-script’’ or ‘‘sometimes it can get
quite heated’’ were seen to contribute to the ineffective
working of the MDT. The lack of buy-in at an organiza-
tional level was reflected in 1 comment:
[The MDT meeting is] often disorganised, poorly
attended at consultant level. No team cohesion
with clerical staff/management. Management do
not respect the importance of MDT often double
book the consultants which forces poor
attendance. (CNS, band 6)
The changes to cancer care delivery and multisite
MDT meetings also presented challenges, for example:
While our local MDT works well, there are conflicts
and issues within the larger MDT which includes
[name of hospitals] Hospitals. I would rarely speak
up in these teleconference meetings. With the NHS
changes and changes to the Cancer Networks the
momentum for change and progress has been
compromised. (specialist nurse, band 6)
When reviewed by pay band (see Table 3), the per-
centage of respondents agreeing that they worked in a
functional and efficient MDT increased for each pay
band (20% at band 5, 35% at band 6, 49% at band 7, 54%
at band 8a, and 80% at band 8b). The percentage of respon-
dents agreeing that they worked in a dysfunctional MDT
was relatively constant as was those who agreed that the
MDT paid attention only to medical issues.
To see whether responses were affected by the num-
ber of years of experience the respondents have, the
responses were broken down into 5 categories by length
of experience (G1, 1Y3, 4Y6, 7Y10, and 910 years) (see
Table 4). There were only 11 responses from nurses with
less than a year’s experience so it was difficult to draw any
conclusions from this group.
Table 2. Number of Respondents by Country
Country in the United Kingdom Responses
England 243
Northern Ireland 3
Scotland 22
Wales 17
UK total 285
FIGURE. Agreed statements about MDT meeting (number indicates number of respondents out of 285 agreeing with the statement).
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The percentage of nurses who agreed that they
worked in a functional and efficient MDT varied from
57% for the group with 1 to 3 years of experience, 37%
for the group with 4 to 6 years of experience, 47% for the
group with 7 to 10 years of experience, and 48% for the
group with more than 10 years of experience. However,
looking at the number of nurses who agreed that they
worked in a dysfunctional MDT, there was a higher re-
sponse (37%) from those with 4 to 6 years of experience
than those with 1 to 3 (10%), 7 to 10 (9%), and more than
10 (10%) years of experience.
As regards the MDT paying attention only to medical
issues, there was a relatively constant response between
the experience groups (11%-19%). When looking at re-
spondents being told of new patients by members of
the MDT, there seems to be a divide between nurses
with 1 to 3 or 4 to 6 years of experience (33% and 32%, re-
spectively) being less likely to be informed of new patients
compared with those with 7 to 10 or more than 10 years of
experience (24% and 25%, respectively). Positive re-
sponses to attending the MDT meeting not being part of
their role and not attending the MDT meeting were very
similar over all the experience groups.
Freedom to Challenge
Looking at the ability to constructively challenge other
members of the MDT during the meeting, 34% of the re-
spondents (n = 97) felt able to constructively challenge
all members of the MDT during the meeting. Although
23% (n = 66) felt able to constructively challenge some
members of the MDT in the meeting but not others in 20%
of responses, they (n = 57) agreed that there were some
members of the team they felt uncomfortable challenging
in or outside the meeting, and 4% (n = 10) found the meet-
ing intimidating. Only 2% (n = 6) agreed that it was not their
role to challenge other members of the MDT. As regards
challenging after themeeting, 21% (n = 61) agreed that they
would constructively challenge members of the MDT after
the meeting or separately in private, whereas 10% (n = 30)
agreed that theywouldwait until after themeeting because
there was not enough time in the meeting.
Another theme that emerged from the free text re-
sponses was the ability to constructively challenge decisions
or views within the MDT meeting.
MDT can be difficult, I would usually challenge
during the MDT, but don’t always get heard, either
due to the general discussion (sometimes quite
Table 4. Agreed Statements About MDT Meeting by Years of Experience
Agreed Statements About MDT
Years of Experience
G1 (N=11) 1Y3 (N=21) 4Y6 (N=38) 7Y10 (N=53) 910 (N=158)
Functionality and operation of the MDT
I work in a functional and efficient MDT. 1 (9%) 12 (57%) 14 (37%) 25 (47%) 75 (48%)
I work in a dysfunctional MDTwhere views are not respected. 3 (27%) 2 (10%) 9 (24%) 5 (9%) 15 (10%)
The MDT meeting pays attention only to medical issues. 3 (27%) 3 (14%) 5 (13%) 11 (19%) 18 (11%)
I am not always told of new patients by members of the MDT. 4 (36%) 7 (33%) 12 (32%) 13 (24%) 39 (25%)
Attending the MDT meeting is not applicable to my role. 3 (27%) 2 (10%) 0 4 (8%) 15 (10%)
I do not attend the MDT meeting. 2 (18%) 2 (10%) 5 (13%) 6 (11%) 18 (11%)
Freedom to challenge within the MDT
I would constructively challenge all members of the MDT in
the meeting.
1 (9%) 5 (24%) 7 (18%) 18 (34%) 66 (42%)
I would constructively challenge some members of the MDT
in the meeting but not others.
1 (9%) 7 (33%) 13 (34%) 12 (23%) 31 (20%)
I would constructively challenge members of the MDT after
the meeting/separately in private.
2 (18%) 4 (19%) 7 (18%) 15 (28%) 33 (21%)
I wait until after the meeting because there is not enough
time during the meeting.
2 (18%) 4 (19%) 6 (16%) 6 (11%) 12 (8%)
There are some members of the team I feel uncomfortable
challenging in or outside the meeting.
3 (27%) 6 (28%) 10 (26%) 13 (24%) 24 (15%)
I do not feel it"s my role to challenge othermembers of theMDT. 1 (9%) 0 2 (5%) 2 (4%) 1 (1%)
I find the MDT meeting intimidating. 1 (9%) 0 1 (3%) 2 (4%) 6 (4%)
Abbreviation: MDT, multi-disciplinary team.
Percentages relate to the percentage of respondents at each experience level who agreed with the relevant statement.
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heated) I feel ignored though sometimes, I don’t
have access to all MDT members to challenge
outside the MDT meeting. Within the meeting
however, I think I have more of a voice than the
other nurse members, I suspect they challenge
some individuals outside the meeting. I believe I
am there to advocate on behalf of patients and
hope if ever I needed discussed in an MDT the CNS
would speak up for me. (CNS, band 7)
It would depend on who was at the MDT as
dynamics change when certain members are not
there. (CNS, band 6)
Finally, 9% (n = 25) agreed that attending the MDT
meeting was not applicable to their role, whereas 11%
(n = 34) did not attend the MDT meeting.
Responses were reviewed by pay band (see Table 3).
Looking at the ability to constructively challenge all mem-
bers of the MDT in the meeting, there is an increase in the
percentage agreeing with this statement, with increasing
band after 6 (20% at band 5, 20% at band 6, 37% at band
7, 46% at band 8a, and 100% at band 8b), whereas the per-
centage of respondents agreeing that there are somemem-
bers of the team they feel uncomfortable challenging is
relatively constant across bands 5 to 8a (20% at band 5, 20%
at band 6, 22% at band 7, and 14% at band 8a) (see Table 3).
Responses were also reviewed by years of experience
(see Table 4). There is again an observed difference be-
tween those with 1 to 3 or 3 to 6 years of experience (24%
and 18%, respectively) and those with 7 to 10 or more than
10 years of experience (34% and 42%, respectively), with
the longer service band feeling abler to challenge. Those
with 1 to 3 or 4 to 6 years of experience were more likely
to agree that they would challenge some members of the
MDT in the meeting but not others (33% and 34%, respec-
tively) compared with those with 7 to 10 or more than
10 years of experience (23% and 20%, respectively). The
rate of agreeing that there were somemembers of the team
they felt uncomfortable challenging in or outside the meet-
ingwas consistent among the groupswith 1 to 3, 4 to 6, and
7 to 10 years of experience (28%, 26%, and24%, respectively)
and slightly reduced in the group with more than 10 years
of experience (15%). The responses to not feeling that it
was part of their role to challenge in the MDT meeting
and finding the MDT meeting intimidating were similar
across all the experience groups.
DISCUSSION
The results obtained in this study demonstrate that there
is a variety of perceptions of the experience of working
in MDT across urology nurses in the United Kingdom.
Because the MDT is a cancer standard in England with
a proscribed membership, the MDT meetings are often
large, andmanypatients are reviewed. A number of studies
have been carried out into the effectiveness of MDT meet-
ings and the contribution of nurses to the MDT meeting
since MDTs were introduced.
Atwal and Caldwell25 looked at nurses’ perceptions of
MDT work in acute healthcare. They reported that 3 bar-
riers hindered teamwork: (1) differing perceptions of
teamwork, (2) different levels of skill acquisitions to func-
tion as a team member, and (3) the dominance of medical
power that influenced interaction in teams.
A study by Fosker andDodwell26 looked at attendances,
time spent on the MDT meeting, and the number of pa-
tients discussed in the MDT for 14 cancer MDTs during a
single week. The results obtained showed that an average
of 10 consultants, less than 1 junior doctor (0.7/meeting),
and 3 ‘‘others’’ (nurses, pharmacy staff, radiographers, and
clerical) attended each meeting. An average of 31 patients
was discussed at eachMDT, and the average time allocated
was 2.14 hours (approximately 4 minutes per patient). The
time spent did not include preparation time.
Lamb et al27 analyzed the contributions of surgeons, on-
cologists, radiologists, pathologists, and clinical nurses toMDT
and reported that surgeons and radiologists had contribu-
tions of higher than average compared with histopathol-
ogists and nurses, which were rated lower than average.
Other studies have found that the CNS is often the
team member assessing the holistic needs of the patient
and acting as the key worker,28 and the same group re-
ported that nurses’ contributions to MDT meetings may
be limited.27
Patient involvement in treatment decisions is central
to UK health policy and a key part of the NHS constitu-
tion, with the phrase ‘‘No decision about me without
me’’ being used to describe the importance of the patient
viewpoint. Taylor et al29 carried out a qualitative inter-
view study looking at ‘‘No decision about me without
me’’ in the context of MDT meetings. The researchers
conducted semistructured interviews with 9 current can-
cer care patients and 12 MDT members from the teams
managing their care. Findings showed that most MDT
members felt that the patients had a limited understand-
ing about the MDT and that, at most, they might
understand that recommendations for treatment were
the result of an MDT discussion between groups of dif-
ferent health professionals. Three patients in the study
recalled being given information about the MDT verbally
by the CNS, and members of the MDT described the im-
portance of the CNS in relation to information giving due
to their level of contact with the patient. The study also
reported instances where patients were presented at the
MDT without team members having previous knowledge
of them and suggested that, if nobody in the MDT knows
the patient, it wasmore likely that the treatment planwould
not be correct.
Eigenmann,30 in a personal view, suggests that crucial
decisions are often made in the MDT without seeing the
216 www.cns-journal.com July/August 2017
Feature Article
patient and suggests that the MDT should always include
an advocate for the patient such as the patient’s general
practitioner or a hospital generalist. He further states that
the opinion of the patient through his/her advocate should
carry the same weight as the specialist opinion.
Multidisciplinary team working should facilitate excel-
lence through collaborativeworking and be the cornerstone
for patient-centered care. However, the poor experience of
MDT working and meetings reported by many nurses in
this study is very concerning with less than half of the re-
spondents agreeing that they worked in a functional and
efficient MDT. Lack of time, disorganization, and the high
numbers of patients to be discussed were all reported as
barriers to efficient MDT working. The ability of nurses to
challenge in the MDT meeting is also very important be-
cause all members of the MDT team should feel able to
challenge in themeeting if appropriate, but again, our find-
ings give cause for concern. All members of the MDT
should feel able to challenge in the meeting if appropriate,
yet around a quarter of nurses reported that there were
some members of the MDT they felt uncomfortable chal-
lenging in or outside the meeting.
Patient advocacy is a significant part of the role of CNS,
and many prostate CNSs are instrumental in helping pa-
tients come to decisions regarding their treatment options,
as well as managing the aftereffects of these treatments.
The American Association of Critical-Care Nurses’ ‘‘Scope
and Standards for Acute Care Specialist Nurse Clinical Prac-
tice’’ report recommends that advocacy, communication,
and responding to diversity are key roles of the CNS,31
and this is emphasized by Gurzick and Kesten32 who
looked at the impact of CNS on clinical pathways with re-
gard to the application of evidence-based practice.
Therapies for prostate cancer often result in significant
quality-of-life issues, which can impact on their survivor-
ship long after treatment has ended. In addition, men with
relapsing or progressing illnesses often have very signifi-
cant physical, psychological, and social issues, which
need to be taken into account in treatment paths. Several
studies have demonstrated the vital role the CNS can play
to identify these issues33 andensuring that they are addressed
when formulating care plans. Another area in which the
CNS can have an important impact is in facilitating family
intervention for patients with prostate cancer because
many of the issues facing men with prostate cancer impact
on spouses, as well as the patient.34
Again, the results of this study suggest that there is a
need for these issues to be taken into account and that this
may not always be the case at present, with 14% of the re-
spondents agreeing that the MDT only took account of
medical issues and 27% agreeing that theywere not always
told of new patients before the MDT. This may make it dif-
ficult to present nonmedical issues, although the CNS is
often the most appropriate member of the team to do this.
CONCLUSIONS
It is apparent that many of the issues raised by previous
studies, which repeatedly arise into the experience of
nurses at MDT and their contribution to the MDT, still
need to be addressed. It is recommended that all teams
review the time allocated for MDT to ensure there is ad-
equate dedicated time both to present each patient and
for preparation. This time should be protected for all
members of the MDT. The wider body of evidence cited
here indicates that this needs to be addressed at an orga-
nizational level, as well as by the local teams.
The structure of meetings should also be reviewed to
ensure that all members’ contributions are heard and val-
ued. More emphasis needs to be given to patients’ nonmed-
ical needs to ensure that ‘‘No decision about mewithout me
without me’’ becomes a reality rather than a catchphrase,
and it is believed by the authors of this study that the CNSs
are the most appropriate person to represent the patients’
views in theMDT given that they tend to have themost con-
tactwith the patient. Thiswould have a significant impact on
patient care and experience and also use the skills and abil-
ities of the CNS, increasing their job satisfaction. The in-
creased emphasis on interprofessional learning includes
teamwork as a key theme; our findings suggest that this
needs to move beyond undergraduate curricula and be-
come embedded into mandatory training and education.35
In conclusion, safe, effective, and efficient teamwork re-
quires empowered membership,36 and examining ways of
MDT working will be key to improving the experience of
MDT working in the future.
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